mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

Visakhapatnam: India reports one of the highest numbers of eye cancer cases in the world, particularly retinoblastoma, which ...